Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN–PI3K–AKT axis
Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN–PI3K–AKT signaling pathway. For this, House Ear Institute–Orga...
Saved in:
Published in | Biochemistry and cell biology Vol. 99; no. 3; pp. 385 - 395 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7
NRC Research Press
01.05.2021
Canadian Science Publishing NRC Research Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN–PI3K–AKT signaling pathway. For this, House Ear Institute–Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K–Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN–PI3K–Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K–Akt signaling pathway to counteract cisplatin ototoxicity. |
---|---|
AbstractList | Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN–PI3K–AKT signaling pathway. For this, House Ear Institute–Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K–Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN–PI3K–Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K–Akt signaling pathway to counteract cisplatin ototoxicity. Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN-PI3K-AKT signaling pathway. For this, House Ear Institute-Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K-Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN-PI3K-Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K-Akt signaling pathway to counteract cisplatin ototoxicity.Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN-PI3K-AKT signaling pathway. For this, House Ear Institute-Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K-Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN-PI3K-Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K-Akt signaling pathway to counteract cisplatin ototoxicity. Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN-PI3K-AKT signaling pathway. For this, House Ear Institute-Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K-Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN-PI3K-Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K-Akt signaling pathway to counteract cisplatin ototoxicity. Key words: resveratrol, cisplatin ototoxicity, miR-455-5p, PTEN, PI3K-Akt, oxidative stress. Le resvératrol est un composé polyphénolique non-flavonoïde présent dans de nombreuses plantes, et il est considéré comme une antitoxine végétale. Cette étude explore les effets du resvératrol régulant le miR-455-5p sur l'ototoxicité induite par le cisplatine par l'intermédiaire de la voie de signalisation PTEN-PI3K-AKT. DescellulesHEI-OC1 (House Ear Institute-Organ of Corti 1) ont été transfectées avec un inhibiteur du miR-455-5p et traitées avec du cisplatine et du resvératrol. La prolifération, l'apoptose et le stress oxydant ont été évalués chez les cellules HEI-OC1. Un modèle de souris avec perte auditive a été établi et les souris ont été traitées avec du cisplatine, du resvératrol ou du cisplatine combiné à du resvératrol par injection intrapéritonéale. Le seuil de réponse auditive du tronc cérébral (RAC) a été mesuré. Les cellules ciliées ont été examinées par coloration en immunofluorescence. L'expression du miR-455-5p, dePTEN et dePI3K-Akt a été détectée. Les résultats de l'expérience dans les celles ont indiqué que le resvératrol favorisait la viabilité et réduisait l'apoptose et le stress oxydant dans les cellules HEI-OC1 traitées au cisplatine. Le resvératrol régulait à la hausse le miR-455-5p, régulait à la baisse PTEN et activait l'axe PI3K-Akt. Ces effets du resvératrol étaient renversés par l'inhibition du miR-455-5p. Les résultats des expériences sur les animaux suggéraient que le resvératrol protégeait l'audition et inhibait les dommages aux cellules ciliées résultant de l'ototoxicité du cisplatine. Le resvératrol augmentait aussi l'expression du miR-455-5p, inhibait l'expression de PTEN et activait l'axe PTEN-PI3K-Akt des tissus de la cochlée chez les souris traitées au cisplatine. On pourrait conclure que le resvératrol augmente l'expression du miR-455-5p pour cibler PTEN et activer la voie de signalization PI3K/AKT pour antagoniser l'ototoxicité du cisplatine. [Traduit par la Rédaction] Mots-clés : resvératrol, ototoxicité du cisplatine, miR-455-5p, PTEN, PI3K-Akt, stress oxydant. |
Abstract_FL | Le resvératrol est un composé polyphénolique non-flavonoïde présent dans de nombreuses plantes, et il est considéré comme une antitoxine végétale. Cette étude explore les effets du resvératrol régulant le miR-455-5p sur l’ototoxicité induite par le cisplatine par l’intermédiaire de la voie de signalisation PTEN–PI3K–AKT. Des cellules HEI-OC1 (House Ear Institute–Organ of Corti 1) ont été transfectées avec un inhibiteur du miR-455-5p et traitées avec du cisplatine et du resvératrol. La prolifération, l’apoptose et le stress oxydant ont été évalués chez les cellules HEI-OC1. Un modèle de souris avec perte auditive a été établi et les souris ont été traitées avec du cisplatine, du resvératrol ou du cisplatine combiné à du resvératrol par injection intrapéritonéale. Le seuil de réponse auditive du tronc cérébral (RAC) a été mesuré. Les cellules ciliées ont été examinées par coloration en immunofluorescence. L’expression du miR-455-5p, de PTEN et de PI3K–Akt a été détectée. Les résultats de l’expérience dans les celles ont indiqué que le resvératrol favorisait la viabilité et réduisait l’apoptose et le stress oxydant dans les cellules HEI-OC1 traitées au cisplatine. Le resvératrol régulait à la hausse le miR-455-5p, régulait à la baisse PTEN et activait l’axe PI3K–Akt. Ces effets du resvératrol étaient renversés par l’inhibition du miR-455-5p. Les résultats des expériences sur les animaux suggéraient que le resvératrol protégeait l’audition et inhibait les dommages aux cellules ciliées résultant de l’ototoxicité du cisplatine. Le resvératrol augmentait aussi l’expression du miR-455-5p, inhibait l’expression de PTEN et activait l’axe PTEN–PI3K–Akt des tissus de la cochlée chez les souris traitées au cisplatine. On pourrait conclure que le resvératrol augmente l’expression du miR-455-5p pour cibler PTEN et activer la voie de signalization PI3K/AKT pour antagoniser l’ototoxicité du cisplatine. [Traduit par la Rédaction] |
Audience | Academic |
Author | Wu, Hui Liu, Yupeng He, Jingchun Yang, Jun Zhang, Fan |
Author_xml | – sequence: 1 givenname: Yupeng surname: Liu fullname: Liu, Yupeng organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China – sequence: 2 givenname: Hui surname: Wu fullname: Wu, Hui organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China – sequence: 3 givenname: Fan surname: Zhang fullname: Zhang, Fan organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China – sequence: 4 givenname: Jun surname: Yang fullname: Yang, Jun organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China – sequence: 5 givenname: Jingchun surname: He fullname: He, Jingchun organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China |
BookMark | eNqVks1u1DAUhSNUJKaFJXsLNrBw8U-ScZajqtBRq1INw9pynJvUVRKntlNNWfUdeEOeBIdBlEGDELqLK9nfObLvPYfJQW97SJKXlBxTyot3pS4xI4xgkmbFk2RGGRE4J4QdJDMiWIEFo_RZcuj9DSGUpYWYJcMK_B04FZxt0Tg4aMZWBfCoMyucZhnOBhQsUn1Qje3NF0Da-CEipkc2xNoYbcI9ujMKdbYaf9w0KFwDulqfXn57-Hq15OexLc7XSG2Mf548rVXr4cXPfpR8fn-6PjnDFx8_LE8WF1jnJAs4Lec1rVn8FklLxTgvVJmVPCeaQZlWtORQpEQIXkKhqrQq8mxecAE654pqzvlR8mbrOzh7O4IPsjNeQ9uqHuzoJct4LggpBI3o6z_QGzu6Pr4uUinlVNBs_kg1qgVp-toGp_RkKhf5nDEqGJm88B6qgT7OuI3rqk083uFf7eH1YG7l79DxHihWBZ3Re13f7ggiE2ATGjV6L5efVv_BXu6yfMtqZ713UMu4_LjxKHHKtJISOSVRxiTKKYlySuLjTH6pBmc65e7_ypMt3zvtwINy-vofku-6NO1O |
CitedBy_id | crossref_primary_10_3390_molecules28227614 crossref_primary_10_1080_17425255_2023_2260737 crossref_primary_10_3390_ijms23137227 crossref_primary_10_1016_j_intimp_2024_112464 crossref_primary_10_1177_10915818231206665 crossref_primary_10_3390_cancers15164187 crossref_primary_10_3390_ijms25084272 crossref_primary_10_3389_fnins_2023_1333131 crossref_primary_10_3390_ijms24087596 crossref_primary_10_1016_j_apsb_2023_11_001 crossref_primary_10_1007_s10555_023_10126_x crossref_primary_10_3389_fphar_2024_1430469 crossref_primary_10_3389_fncel_2023_1197051 crossref_primary_10_3389_fphar_2022_910308 crossref_primary_10_1007_s10142_023_01173_2 crossref_primary_10_2174_0115672050272577231120060909 crossref_primary_10_3390_ani13030446 crossref_primary_10_1016_j_ecoenv_2022_113992 crossref_primary_10_1007_s11427_024_2803_1 crossref_primary_10_3389_fonc_2024_1453164 crossref_primary_10_3390_antiox13121578 crossref_primary_10_3390_medicina59112045 |
Cites_doi | 10.1016/j.freeradbiomed.2019.03.019 10.1080/08923973.2019.1666406 10.1002/ar.22594 10.3892/ijmm.2020.4633 10.3390/ijms20205220 10.1044/2017_AJA-17-0074 10.1186/s12868-020-00588-y 10.1016/j.jtemb.2019.06.002 10.1016/j.jhazmat.2015.11.060 10.1111/1759-7714.12400 10.1007/s12264-018-0324-5 10.1039/D0FO00469C 10.1016/j.canlet.2019.03.043 10.1002/jcp.28755 10.1016/j.heares.2013.02.002 10.1016/j.mvr.2020.103988 10.1242/bio.016758 10.1007/s00405-019-05635-x 10.1159/000485312 10.1016/j.jinorgbio.2019.110699 10.1016/j.ijporl.2014.11.008 10.1016/j.heares.2015.04.002 10.1016/j.toxlet.2020.04.005 10.3390/molecules24071344 10.1016/j.toxlet.2015.06.012 10.3791/60299 10.3892/mmr.2019.9943 10.3389/fncel.2017.00137 10.1016/j.yexcr.2017.09.019 10.1038/s41419-018-0888-z 10.3390/nu11050946 10.1111/nyas.13422 10.3390/ijms20215423 10.3892/mmr.2020.11407 10.3892/mmr.2017.7912 10.1007/s10162-020-00759-y 10.22038/ijorl.2019.41914.2368 10.3390/molecules25010063 10.1002/cpt.1483 10.1155/2019/6595189 10.1111/j.1365-2990.2010.01076.x 10.1016/j.semcancer.2019.12.008 10.3390/ijms20184497 10.1016/j.neurobiolaging.2019.03.013 10.14715/cmb/2020.66.5.25 10.1016/j.tibs.2014.02.006 10.1016/j.saa.2019.117149 10.1016/j.taap.2018.06.010 10.3390/nu10111651 10.1038/cddis.2017.314 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 NRC Research Press 2021 Published by NRC Research Press |
Copyright_xml | – notice: COPYRIGHT 2021 NRC Research Press – notice: 2021 Published by NRC Research Press |
DBID | AAYXX CITATION ISN ISR 7QO 7QP 7QR 7TK 7TM 7U7 7U9 8FD C1K FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1139/bcb-2020-0459 |
DatabaseName | CrossRef Gale In Context: Canada Gale In Context: Science Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Genetics Abstracts Biotechnology Research Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Virology and AIDS Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1208-6002 |
EndPage | 395 |
ExternalDocumentID | A672218201 10_1139_bcb_2020_0459 bcb-2020-0459 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- -~X .55 .GJ 00T 0R~ 23N 36B 3O- 4.4 53G 5GY 5RE 5RP 7X2 7X7 88E 88I 8AF 8AO 8CJ 8FE 8FG 8FH 8FI 8FJ 8FQ 8G5 A8Z AAIKC AAMNW AAYJJ ABDBF ABEFU ABJCF ABJNI ABUWG ACGFO ACGFS ACGOD ACIWK ACPRK ACSVP ACUHS ADBBV AEUYN AFKRA AFRAH AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS APEBS ATCPS AZQEC BBNVY BCR BCU BEC BENPR BES BGLVJ BHPHI BLC BPHCQ BVXVI CAG CCPQU COF CS3 D1I D1J D8U DATHI DWQXO EAD EAP EBC EBD EBS ECC EJD EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ GUQSH HCIFZ HF~ HMCUK HZ~ H~9 IAG IAO ICQ IEA IGS IHR INH INR IOF IPNFZ ISN ISR ITC KB. L7B LK8 M0K M1P M2O M2P M2Q M3C M3G M7P MV1 MVM NMEPN NRXXU NYCZX O9- ONR OVD P2P PADUT PDBOC PEA PHGZM PHGZT PQQKQ PRG PROAC PSQYO PV9 QF4 QM4 QN7 QO4 QRP RIG RRCRK RRP RZL SJFOW SV3 TEORI TUS UKHRP VQG WH7 X7M ZAY ZGI ZXP ~KM AAYXX CITATION PJZUB PPXIY PQGLB 7QO 7QP 7QR 7TK 7TM 7U7 7U9 8FD C1K FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c605t-4b7f1f213904ba2339ab5b360c2eb4d1b3e940883be9ad4d9657938ec63a1c333 |
ISSN | 0829-8211 1208-6002 |
IngestDate | Sun Aug 24 03:24:32 EDT 2025 Wed Aug 13 06:35:31 EDT 2025 Wed Mar 19 01:01:48 EDT 2025 Thu Jun 12 23:24:06 EDT 2025 Tue Jun 10 15:32:27 EDT 2025 Tue Jun 10 20:23:15 EDT 2025 Fri Jun 27 03:49:53 EDT 2025 Fri Jun 27 05:10:46 EDT 2025 Thu Apr 24 23:05:09 EDT 2025 Tue Aug 05 12:05:18 EDT 2025 Fri Jun 13 18:33:44 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c605t-4b7f1f213904ba2339ab5b360c2eb4d1b3e940883be9ad4d9657938ec63a1c333 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PQID | 2541318157 |
PQPubID | 47596 |
PageCount | 11 |
ParticipantIDs | gale_infotracgeneralonefile_A672218201 crossref_citationtrail_10_1139_bcb_2020_0459 gale_incontextgauss_ISR_A672218201 gale_infotraccpiq_672218201 gale_infotracacademiconefile_A672218201 crossref_primary_10_1139_bcb_2020_0459 proquest_miscellaneous_2536800981 gale_incontextgauss_ISN_A672218201 proquest_journals_2541318157 gale_infotracmisc_A672218201 nrcresearch_primary_10_1139_bcb_2020_0459 |
PublicationCentury | 2000 |
PublicationDate | 20210501 |
PublicationDateYYYYMMDD | 2021-05-01 |
PublicationDate_xml | – month: 05 year: 2021 text: 20210501 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | 1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7 |
PublicationPlace_xml | – name: 1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7 – name: Ottawa |
PublicationTitle | Biochemistry and cell biology |
PublicationYear | 2021 |
Publisher | NRC Research Press Canadian Science Publishing NRC Research Press |
Publisher_xml | – name: NRC Research Press – name: Canadian Science Publishing NRC Research Press |
References | refg40/ref40 refg18/ref18 refg22/ref22 refg36/ref36 refg11/ref11 refg25/ref25 refg6/ref6 refg15/ref15 refg29/ref29 refg43/ref43 refg26/ref26 refg14/ref14 refg5/ref5 refg37/ref37 refg19/ref19 refg21/ref21 refg7/ref7 refg4/ref4 refg46/ref46 refg48/ref48 refg10/ref10 refg1/ref1 refg32/ref32 refg35/ref35 refg42/ref42 refg24/ref24 refg16/ref16 refg50/ref50 refg13/ref13 refg27/ref27 refg20/ref20 refg38/ref38 refg45/ref45 refg49/ref49 refg31/ref31 refg9/ref9 refg34/ref34 refg8/ref8 refg2/ref2 refg23/ref23 refg17/ref17 refg30/ref30 refg12/ref12 refg28/ref28 refg41/ref41 refg39/ref39 refg3/ref3 Zhang B. (refg47/ref47) 2020; 66 refg44/ref44 refg33/ref33 |
References_xml | – ident: refg37/ref37 doi: 10.1016/j.freeradbiomed.2019.03.019 – ident: refg9/ref9 doi: 10.1080/08923973.2019.1666406 – ident: refg1/ref1 doi: 10.1002/ar.22594 – ident: refg6/ref6 doi: 10.3892/ijmm.2020.4633 – ident: refg13/ref13 doi: 10.3390/ijms20205220 – ident: refg32/ref32 doi: 10.1044/2017_AJA-17-0074 – ident: refg46/ref46 doi: 10.1186/s12868-020-00588-y – ident: refg25/ref25 doi: 10.1016/j.jtemb.2019.06.002 – ident: refg42/ref42 doi: 10.1016/j.jhazmat.2015.11.060 – ident: refg43/ref43 doi: 10.1111/1759-7714.12400 – ident: refg28/ref28 doi: 10.1007/s12264-018-0324-5 – ident: refg48/ref48 doi: 10.1039/D0FO00469C – ident: refg50/ref50 doi: 10.1016/j.canlet.2019.03.043 – ident: refg4/ref4 doi: 10.1002/jcp.28755 – ident: refg41/ref41 doi: 10.1016/j.heares.2013.02.002 – ident: refg30/ref30 doi: 10.1016/j.mvr.2020.103988 – ident: refg14/ref14 doi: 10.1242/bio.016758 – ident: refg39/ref39 doi: 10.1007/s00405-019-05635-x – ident: refg44/ref44 doi: 10.1159/000485312 – ident: refg10/ref10 doi: 10.1016/j.jinorgbio.2019.110699 – ident: refg22/ref22 doi: 10.1016/j.ijporl.2014.11.008 – ident: refg19/ref19 doi: 10.1016/j.heares.2015.04.002 – ident: refg49/ref49 doi: 10.1016/j.toxlet.2020.04.005 – ident: refg23/ref23 doi: 10.3390/molecules24071344 – ident: refg17/ref17 doi: 10.1016/j.toxlet.2015.06.012 – ident: refg8/ref8 doi: 10.3791/60299 – ident: refg24/ref24 doi: 10.3892/mmr.2019.9943 – ident: refg15/ref15 doi: 10.3389/fncel.2017.00137 – ident: refg26/ref26 doi: 10.1016/j.yexcr.2017.09.019 – ident: refg20/ref20 doi: 10.1038/s41419-018-0888-z – ident: refg31/ref31 doi: 10.3390/nu11050946 – ident: refg18/ref18 doi: 10.1111/nyas.13422 – ident: refg35/ref35 doi: 10.3390/ijms20215423 – ident: refg33/ref33 doi: 10.3892/mmr.2020.11407 – ident: refg16/ref16 doi: 10.3892/mmr.2017.7912 – ident: refg11/ref11 doi: 10.1007/s10162-020-00759-y – ident: refg36/ref36 doi: 10.22038/ijorl.2019.41914.2368 – ident: refg5/ref5 doi: 10.3390/molecules25010063 – ident: refg7/ref7 doi: 10.1002/cpt.1483 – ident: refg29/ref29 doi: 10.1155/2019/6595189 – ident: refg38/ref38 doi: 10.1111/j.1365-2990.2010.01076.x – ident: refg40/ref40 doi: 10.1016/j.semcancer.2019.12.008 – ident: refg27/ref27 doi: 10.3390/ijms20184497 – ident: refg45/ref45 doi: 10.1016/j.neurobiolaging.2019.03.013 – volume: 66 start-page: 142 issue: 5 year: 2020 ident: refg47/ref47 publication-title: Cell. Mol. Biol. (Noisy-le-grand). doi: 10.14715/cmb/2020.66.5.25 – ident: refg12/ref12 doi: 10.1016/j.tibs.2014.02.006 – ident: refg34/ref34 doi: 10.1016/j.saa.2019.117149 – ident: refg21/ref21 doi: 10.1016/j.taap.2018.06.010 – ident: refg3/ref3 doi: 10.3390/nu10111651 – ident: refg2/ref2 doi: 10.1038/cddis.2017.314 |
SSID | ssj0012498 |
Score | 2.4355488 |
Snippet | Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the... |
SourceID | proquest gale crossref nrcresearch |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 385 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase AKT protein Analysis Antitoxins Apoptosis Brain stem Cell injury Cell proliferation Chemotherapy Cisplatin cisplatin ototoxicity Cochlea Coloration Flavonoids Gene expression Hair Hair cells Hearing Hearing loss Immunofluorescence Injection Kinases MicroRNA miR-455-5p Organ of Corti Ototoxicity ototoxicité du cisplatine Oxidative stress Physiological aspects PI3K–Akt Properties PTEN PTEN protein Resveratrol resvératrol Signal transduction Signaling stress oxydant |
Title | Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN–PI3K–AKT axis |
URI | http://www.nrcresearchpress.com/doi/abs/10.1139/bcb-2020-0459 https://www.proquest.com/docview/2541318157 https://www.proquest.com/docview/2536800981 |
Volume | 99 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbGJgRcINhAjBVkEBpCI9DYSdpcdj9Vt6Fq6jZpXEW2645ILA1NMo1d8Q48CO_Ek3BO4qSJtvGnSmlqHzmpz5fjY-f4O4S8krY7mXSEY8kxcy3H1toSWuJymFbM8XhnLPMA2aE3OHb2TtyThYUftailLJXv1OW1-0r-R6tQBnrFXbL_oNmqUSiAc9AvHEHDcPwrHY90co6kyBhrnsWzIq28TjbOwpHluK7lxuhaQt-JU3h0L_WGCpMYg9_AR0zhcxEqdMLPQ4EZcfJEXmbz1MHRzrCMg-AHu3y_-gFO4Ya4CJPG2-AQ824VieOKjXK4Imj4naqQnzDL7X0WazNa4liQlw2y8MoCdn8O24-maC-L6osUzJ6HBJr9Z4ZpoTRYtTW24WirijJsxJ3kJpD5VpcZc6wLE83aXQvfJtZteJFkyWCV1wwyLxICmbGdFwk9rw4bHFlXpZIAL4bhroalvEHPPegdBgfb_eDD7nD_FlliMC8Bw7rU29ze7FcvrmA2mw_-5Y2XtK7cf99ovuEGGWfgXjRThuLp0xXXIPd3jh6Q-2aiQnsF6h6SBR0tk5VeJNLp2Ve6TvPQ4VzBy-T2Znl2Z6vEwQqJa_CkNXjSOTxpOqVzeNIKnrQGTwrwpHN4UoAnRXj-_PYdgQlfAEmKkHxEjvs7R1sDyyT4sBTMolPLkZ2JPWHQOW1HCsa5L6QruddWTEtnbEuufQeGQS61L8bO2PdcGE66Wnlc2Ipz_pgsRtNIP0HqAd3RbTb2HKUdwT1f-I6Q4E7r7sRrS3eVvC37O1CG_R6TsHwO8lkw9wNQT4DqCVA9q2S9Eo8L2pebBF-i8gKkUokwVutUZEkS7B4Og57XYXl-BPtGoVFD6LURmkzhzpQw-2Pg_yFFW0NyrSGp4vBLUKtdb9SeFvT11zXTaggCOlSj-k0Nj3_qhVaJ1sDYxyRgLjjIMIFwO6vkRVWNV8G4zkhPM5ThXhc5je2nv29ijdyd25UWWUxnmX4G04FUPjeP4C8JhQlk |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Resveratrol+upregulates+miR-455-5p+to+antagonize+cisplatin+ototoxicity+via+modulating+the+PTEN%E2%80%93PI3K%E2%80%93AKT+axis&rft.jtitle=Biochemistry+and+cell+biology&rft.au=Liu%2C+Yupeng&rft.au=Wu%2C+Hui&rft.au=Zhang%2C+Fan&rft.au=Yang%2C+Jun&rft.date=2021-05-01&rft.pub=Canadian+Science+Publishing+NRC+Research+Press&rft.issn=0829-8211&rft.eissn=1208-6002&rft.volume=99&rft.issue=3&rft.spage=385&rft.epage=395&rft_id=info:doi/10.1139%2Fbcb-2020-0459&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0829-8211&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0829-8211&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0829-8211&client=summon |